A5026317115- Pharmacological Effects of Natural Compounds
- Inflammatory Bowel Disease
- Fungal Biology and Applications
- Diabetes Management and Research
- Polysaccharides and Plant Cell Walls
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Gastrointestinal motility and disorders
- Phytochemical compounds biological activities
- Diabetes Management and Education
- Andrographolide Research and Applications
- Phytochemistry and Bioactivity Studies
- Eosinophilic Esophagitis
- Neurological and metabolic disorders
- Complementary and Alternative Medicine Studies
- Microscopic Colitis
- Diabetes and associated disorders
Sykehuset i Vestfold
2020
Oslo University Hospital
2016-2019
Ingestion of AndoSan™, based on the mushroom Agaricus blazei Murill, has previously been shown to exhibit anti-inflammatory effects because reduction pro-inflammatory cytokines in healthy individuals and patients with ulcerative colitis. In this randomized single-blinded placebo controlled study we examined whether intake AndoSan™ also resulted clinical effects.50 symptomatic colitis were block-randomized blinded for oral daily or 21 days' experimental period. The reported scores symptoms,...
Ingestion of the Agaricus blazei Murill-based mushroom extract AndoSan™ has been shown in randomized placebo-controlled studies to improve symptoms Crohn's disease (CD) and ulcerative colitis (UC) also fatigue quality life latter patients. The aim was examine whether this clinical impact intake could be explained by influence on foremost pro-inflammatory cytokines Fifty patients with symptomatic UC CD were blinded for oral daily or placebo. Blood samples taken before (visit 1) after 21 days'...
Background Ingestion of AndoSanTM, based on the mushroom Agaricus blazei Murill, has previously shown an anti-inflammatory effect through reduction pro-inflammatory cytokines in healthy individuals and patients with Crohn's disease (CD). In this randomized single-blinded placebo-controlled study we examined whether intake AndoSanTM also resulted clinical effects. Methods Findings 50 symptomatic CD were for oral daily consumption or placebo a 21-day experimental period, per-protocol study....
Objectives: Crohn's disease (CD) and ulcerative colitis (UC) have been regarded as autoimmune Th-1/Th-17- Th-2-associated conditions, respectively. The aim of the study was to examine possible differences in allergen sensitization between these diseases relative normal blood donors (BD). Materials methods: Plasma from 29 UC 37 CD patients with moderate activity 100 healthy age- gender-matched BD, were analyzed for specific IgE 22 food- 28 inhalation allergens using EUROLINE atopy screen....